SOX7 and cancer: MiR-452-5P was up-regulated and predicted poor patient survival and advanced TNM stage in HCC patients, and miR-452 was identified to promote cancer stem cells by inhibiting Sox7 through activating Wnt/β-Catenin signaling pathway [21].